Medical Properties Trust, Inc.
NYSE:MPTREIT - Healthcare Facilities
-$0.02 today
- Market cap
- $959.91M
- Beta
- 1.46
- P/E (TTM)
- -22.0
- EPS (TTM)
- -$0.21
- Dividend yield
- 7.55%
Volume 29.38M
Average 5.52M
MPT Selling, General & Admin
Overhead costs of running the business, including sales, marketing, management, and administrative staff.
Medical Properties Trust, Inc.NYSE: MPT
Selling, General & Admin · Q2 FY2026 · quarter ended Jun 2026
Selling, general & admin growth accelerates
Q2 FY2026 selling, general & admin of $34.77M rose 32.7% year over year, ahead of the -2.9% change in trailing-twelve-month selling, general & admin. Sequentially, it rose 8.0% from the prior quarter. Over 3 fiscal years it compounded at -6.7% a year.
Context
- Selling, general & admin amounted to 13.4% of revenue in FY2025, unchanged from a year earlier.
- Selling, general & admin increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether selling, general & admin reaches the consensus estimate from 1 analysts of $124.8M (-4.3%) for the fiscal year ending Dec 2026, a slowdown from the -2.5% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $34.77M+8.0% QoQ
- Last fiscal yearDec 2025
- $130.43M-2.5% YoY
- LTMJun 2026
- $129.3M-2.9% YoY
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Selling, General & Admin history
USD · from the income statement
- Latest · FY2025
- 130.43M USD
- Year-over-year change
- -2.5%
- 4-year CAGR
- -2.7%
| Period | Period end | Selling, General & Admin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 130.43M | -2.5% |
| FY2024 | 2024-12-31 | 133.79M | -8.1% |
| FY2023 | 2023-12-31 | 145.59M | -9.3% |
| FY2022 | 2022-12-31 | 160.49M | +10.2% |
| FY2021 | 2021-12-31 | 145.64M | — |
Selling, General & Admin vs competitors
How MPT compares with its peers on the latest reported figures
- MPT's LTM Jun 2026 selling, general & admin of $129.3M is the 3rd highest of the 9 companies compared; the peer median is $79.25M.
- Its year-over-year change of -2.9% is the 6th highest of 9, against a peer median of +3.9%.
- Selling, general & admin amounts to 12.7% of revenue for MPT, versus a peer median of 5.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.45B | +3.8% | +6.9% | 19.2% | |
| LTM Sep 2026 | $288.37M | +56.3% | +22.3% | 4.7% | |
MPTMedical Properties Trust, Inc. | LTM Jun 2026 | $129.3M | -2.9% | -6.7% | 12.7% |
| LTM Jun 2026 | $96.71M | -31.5% | -6.8% | 5.1% | |
| LTM Sep 2026 | $94.32M | +4.0% | -11.6% | 4.2% | |
| LTM Jun 2026 | $64.18M | -36.0% | — | 5.0% | |
| LTM Jun 2026 | $60.15M | +18.7% | +10.7% | 7.0% | |
| LTM Sep 2026 | $55.78M | +9.8% | +3.4% | 6.2% | |
| LTM Sep 2026 | $25.34M | -16.0% | +10.5% | 6.4% | |
| Peer median (excluding MPT) | $79.25M | +3.9% | +6.9% | 5.6% | |
Competitors are the stored peer set for MPT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.54B | 1.54B | 871.8M | 995.55M | 972.02M |
| Cost of Revenue | 39.1M | 45.7M | 41.57M | 27.26M | 36.42M |
| Gross Profit | 1.51B | 1.5B | 830.23M | 968.29M | 935.61M |
| Gross Margin | 97.5% | 97.0% | 95.2% | 97.3% | 96.3% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 145.64M | 160.49M | 145.59M | 133.79M | 130.43M |
| Operating Expenses | 466.89M | 493.47M | 748.95M | 581.45M | 395.83M |
| Depreciation & Amortization | 333.78M | 345.58M | 616.13M | 453.75M | 272.82M |
| EBITDA | 1.46B | 1.67B | 340.24M | (1.49B) | 545.86M |
| EBITDA Margin | 94.5% | 108.5% | 39.0% | -149.5% | 56.2% |
| Operating Income | 1.04B | 1B | 81.28M | 386.85M | 539.78M |
| Operating Margin | 67.2% | 65.1% | 9.3% | 38.9% | 55.5% |
| Interest Income | 0 | 0 | 0 | 0 | 39.74M |
| Interest Expense | 395.04M | 368.49M | 410.89M | 422.12M | 510.36M |
| Other Income / Expenses | (307.8M) | (43.96M) | (768.06M) | (2.75B) | (777.09M) |
| Income Before Tax | 730.89M | 959.72M | (686.77M) | (2.36B) | (237.32M) |
| Pre-Tax Margin | 47.3% | 62.2% | -78.8% | -237.5% | -24.4% |
| Income Tax Expense | 73.95M | 55.9M | (130.68M) | 44.1M | 38.62M |
| Net Income | 656.02M | 902.6M | (556.48M) | (2.41B) | (277.05M) |
| Net Margin | 42.5% | 58.5% | -63.8% | -242.1% | -28.5% |
| EPS (Basic) | 1.11 | 1.50 | (0.93) | (4.02) | (0.46) |
| EPS (Diluted) | 1.11 | 1.50 | (0.93) | (4.02) | (0.46) |
| Weighted Avg Shares | 588.82M | 598.63M | 598.52M | 600.32M | 600.89M |
| Weighted Avg Shares (Diluted) | 590.14M | 598.84M | 598.52M | 600.32M | 600.89M |
Medical Properties Trust, Inc.
NYSE:MPT
Intrinsic Alpha fair value
Locked
Current Price
$1.63
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.